Clinical effect of Hongteng decoction combined with levofloxacin in the treatment of chronic pelvic inflammatory disease and its effect on inflammatory factors

Objective: To explore the clinical therapeutic effect of Hongteng decoction combined with levofloxacin on chronic pelvic inflammatory disease (CPID) patients and its expression factors. Methods: 72 CPID who were diagnosed treated in Fourth Hospital Shijiazhuang City from January 2020 to December selected randomly divided into observation group (n = 36) control 36). The was retention enema basis group. Both groups continuously for 2 courses. effects two compared, changes related indexes such as interleukin-2 (IL-2), interleukin-10 (IL-10), C-reactive protein (CRP) tumor necrosis factor-α (TNF-α) compared between before after treatment. score quality life occurrence adverse reactions treatment compared. Results: total effective rate significantly higher than that group, difference statistically significant (P<0.05). IL-2, IL-10, CRP TNF-α there no statistical significance (P>0.05). After treatment, IL-2 IL-10 lower There differences physical pain, function, social function mental health scores those incidence Conclusion: has definite efficacy CPID, which can effectively improve symptoms inhibit response, is worthy promotion.